Literature DB >> 28738388

Updated Friedman Staging System for Obstructive Sleep Apnea.

Michael Friedman, Anna M Salapatas, Lauren B Bonzelaar.   

Abstract

In the practice of sleep medicine, the first step is identification of those patients at high risk for sleep apnea. Nearly every physician and every hospital has preferred methods of screening. Many patient questionnaires or surveys as well as some objective physical measurements have been suggested to predict the presence of sleep apnea. Screening is well established, and laboratory and home testing are widely available. An early assessment with a physical examination can help direct treatment planning. The Friedman tongue position, lingual tonsil hypertrophy grading, and the effects of oral positioning on the hypopharynx should be used in early assessment for treatment planning, and as screening tools to assess the sight of obstruction. Although these screening tools are not substitutes for drug-induced sleep endoscopy (DISE), they are crucial in early assessment as many patients do not require surgery or DISE early in the evaluation.
© 2017 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2017        PMID: 28738388     DOI: 10.1159/000470859

Source DB:  PubMed          Journal:  Adv Otorhinolaryngol        ISSN: 0065-3071


  25 in total

1.  Recognizing Poor Sleep Quality Factors During Oral Health Evaluations.

Authors:  Kelly Schroeder; JoAnn R Gurenlian
Journal:  Clin Med Res       Date:  2019-06

2.  Partial epiglottectomy improves residual apnea-hypopnea index in patients with epiglottis collapse.

Authors:  Se-Hyun Jeong; Chung Man Sung; Sang Chul Lim; Hyung Chae Yang
Journal:  J Clin Sleep Med       Date:  2020-09-15       Impact factor: 4.062

Review 3.  Utility of the modified Mallampati grade and Friedman tongue position in the assessment of obstructive sleep apnea.

Authors:  Jason L Yu; Ilene Rosen
Journal:  J Clin Sleep Med       Date:  2020-01-13       Impact factor: 4.062

4.  Treatment of snoring disorder with a non-ablactive Er:YAG laser dual mode protocol. An interventional study.

Authors:  Luís Monteiro; Ana Macedo; Luis Corte-Real; Filomena Salazar; José-Júlio Pacheco
Journal:  J Clin Exp Dent       Date:  2020-06-01

5.  Influence of apnea vs hypopnea predominance in predicting mean therapeutic positive airway pressures among patients with obstructive sleep apnea.

Authors:  Jason L Yu; Yifan Liu; Akshay Tangutur; Monique Arnold; Everett G Seay; Alan R Schwartz; Raj C Dedhia
Journal:  J Clin Sleep Med       Date:  2021-11-01       Impact factor: 4.062

6.  Modified Uvulopalatopharyngoplasty with Tonsillectomy in Treatment of Obstructive Sleep Apnoea.

Authors:  G N Nikisha; S Mohana Karthikeyan
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2021-02-13

7.  Predicting upper airway collapse sites found in drug-induced sleep endoscopy from clinical data and snoring sounds in patients with obstructive sleep apnea: a prospective clinical study.

Authors:  Zhengfei Huang; Pien F N Bosschieter; Ghizlane Aarab; Maurits K A van Selms; Joost W Vanhommerig; Antonius A J Hilgevoord; Frank Lobbezoo; Nico de Vries
Journal:  J Clin Sleep Med       Date:  2022-09-01       Impact factor: 4.324

8.  The role of drug-induced sleep endoscopy: predicting and guiding upper airway surgery for adult OSA patients.

Authors:  Yan Wang; Chuanyu Sun; Xinhua Cui; Ying Guo; Qirong Wang; Hui Liang
Journal:  Sleep Breath       Date:  2018-10-01       Impact factor: 2.816

9.  Tongue peak pressure: a tool to aid in the identification of obstruction sites in patients with obstructive sleep apnea/hypopnea syndrome.

Authors:  Carlos O'Connor-Reina; Guillermo Plaza; Maria Teresa Garcia-Iriarte; Jose Maria Ignacio-Garcia; Peter Baptista; Juan Carlos Casado-Morente; Eugenio De Vicente
Journal:  Sleep Breath       Date:  2019-11-19       Impact factor: 2.816

10.  Upper airway collapse characteristics in adult patients with OSA and previous tonsillectomy.

Authors:  Chen Zhao; Alonço Viana; Yifei Ma; Robson Capasso
Journal:  Sleep Breath       Date:  2021-07-28       Impact factor: 2.816

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.